UK Stock Market News Today – 7-Mar-2018
Anpario (ANP) – 425p – £98.3m – PER 25.8
Final Results For The 12 Months To End December 2017 – Revenues up 20% to £29.2m (2016: £24.3m), PBT up 27% to £3.4m (2016: £2.7m), Diluted EPS up by 13% to 14.17p (2016: 12.58p). NetCash £13.6m (2016: £11.1m) and the total Dividend is 18% up on last year, 6.5p. Optimistic about the outlook, potential issues being FX and raw material prices.
I quite like this and I think if the outlook was a little more optimistic I would be more interested. For now I will remain Neutral.
Bioquell (BQE) – 322.5p – £72.5m – PER 28.0
Preliminary Results For The 12 Months To End December 2017 – Revenue up 6% (CC) to £29.2m (2016: £26.5 million), PBT of £3.3 million (2016: £0.1 million), Diluted EPS 10.8p (2016:1.2p) with Cash(and equivalents) at £14.6 million (2016: £8.8 million). 2018 has started in-line.
Doubled in the past 12 months but I don’t see enough here at present to tempt me.
Lookers (LOOK) – 93.3p – £370.0m – PER 6.42
Results For The 12 Months To End December 2017 – Revenue up 15% £4,696m (vs £4,088m), Adjusted PBT of £68.4m (vs £64.9m), Adjusted EPS up 1.3% (14.57p) and the Dividend is up 5%. Q1 expected to be in-line with management expectations. Share Buyback also announced, up to £10m.
At present, I am no more keen on buying this today than I was yesterday.
Microgen (MCGN) – 500p – £304.4m – PER 27.3
Preliminary Results For The 12 Months To End December 2017 – Revenue up 46% to £62.6m (2016: £43.0m), 37% excluding the benefit of recent acquisitions. Adjusted Operating Profit up 43% to £13.6m (2016: £9.5), Statutory £11.1m (2016: £8.2m). Adjusted EPS up 39% to 17.1p (2016: 12.3p), Total Dividend for the year will be 6.25p (2016: 5.0 pence), an increase of 25%. Cash is £19.1m (2016: £23.8m). The Chairman states “The Group enters 2018 well positioned with good revenue visibility and an encouraging pipeline of opportunities”.
I am very tempted here and if I don’t get some this morning this will go on my Watchlist, 440p.
Netcall (NET) – 50.8p – £72.5m – PER 21.6
Interim Results For The 6 Months To End December 2017 – Revenue up 32% to £10.7m (H1 2017: £8.09m), PBT £0.28m (H1 F17: £ 0.92m) after acquisition related expenses.
Just out of interest, I will keep this on my Watchlist, 44p.
ST Ives (SIV) – Now Kin And Carta (KCT) – 74.2p – £105.9m – PER 5.64
Results For The 27 Weeks To 2 February 2018 – Revenue up 7% with a Statutory Loss Before Tax of -£15.0m (-£3.1m last time).
Net Debt is down but at £42.2m (with a Pension Deficit of £15.8m) that’s a sizeable chuck of worry. I will not be investing here at present.
Volvere (VLE) – 880p – £32.3m – PER 22.9
Trading Update For The 12 Months To End December 2017 – Expects to report record Revenue of approximately £43.2m (2016: £33.0m) and PBT of £3.22m (2016: £1.94m). Cash of £18.4m.
Had this on my Watchlist at 880p and seriously considering paying up here.
As always, all comment most welcome – Have a great day!